Ueda Y, Kiyonaka S, Selfors L, Inoue K, Harada H, Doura T
Nat Cell Biol. 2025; 27(3):530-543.
PMID: 39984655
DOI: 10.1038/s41556-025-01617-w.
McGhee A, McGhee E, Famiglietti J, Sawyer W
In Vitro Model. 2025; 1(4-5):309-321.
PMID: 39872233
PMC: 11756474.
DOI: 10.1007/s44164-022-00037-6.
Bin Masroni M, Koay E, Lee V, Ng S, Tan S, Tan K
Exp Mol Med. 2025; 57(1):30-40.
PMID: 39774289
PMC: 11799181.
DOI: 10.1038/s12276-024-01387-9.
Ghosh S, Dey A, Chakrabarti A, Bhuniya T, Indu N, Hait A
J Cell Mol Med. 2024; 28(23):e70052.
PMID: 39659020
PMC: 11632122.
DOI: 10.1111/jcmm.70052.
Lu Z, Mo S, Xie D, Zhai X, Deng S, Zhou K
Nature. 2024; 636(8041):233-240.
PMID: 39478225
DOI: 10.1038/s41586-024-08133-1.
Emergence and impact of theranostic-nanoformulation of triple therapeutics for combination cancer therapy.
Rajora A, Ahire E, Rajora M, Singh S, Bhattacharya J, Zhang H
Smart Med. 2024; 3(1):e20230035.
PMID: 39188518
PMC: 11235932.
DOI: 10.1002/SMMD.20230035.
Electroporation with Calcium or Bleomycin: First Application in an In Vivo Uveal Melanoma Patient-Derived Xenograft Model.
Anastasova R, Fiorentzis M, Liu H, Dalbah S, Bechrakis N, Seitz B
Pharmaceuticals (Basel). 2024; 17(7).
PMID: 39065755
PMC: 11279991.
DOI: 10.3390/ph17070905.
Biosensors for Cancer Biomarkers Based on Mesoporous Silica Nanoparticles.
Mladenovic M, Jaric S, Mundzic M, Pavlovic A, Bobrinetskiy I, Knezevic N
Biosensors (Basel). 2024; 14(7).
PMID: 39056602
PMC: 11274377.
DOI: 10.3390/bios14070326.
An agent-based modelling framework to study growth mechanisms in mutant cell alveolar type II cells.
Coggan H, Weeden C, Pearce P, Dalwadi M, Magness A, Swanton C
R Soc Open Sci. 2024; 11(7):240413.
PMID: 39021764
PMC: 11252670.
DOI: 10.1098/rsos.240413.
A modelling framework for cancer ecology and evolution.
Adler F
J R Soc Interface. 2024; 21(216):20240099.
PMID: 39013418
PMC: 11251767.
DOI: 10.1098/rsif.2024.0099.
Examination of the role of mutualism in immune evasion.
Gourmet L, Walker-Samuel S, Mallick P
Front Oncol. 2024; 14:1406744.
PMID: 38779085
PMC: 11109368.
DOI: 10.3389/fonc.2024.1406744.
Promising preclinical models for lung cancer research-lung cancer organoids: a narrative review.
Chen X, Ye L, Wang H, Liu X, Zhao L, Xu K
Transl Lung Cancer Res. 2024; 13(3):623-634.
PMID: 38601435
PMC: 11002517.
DOI: 10.21037/tlcr-23-341.
Multicellular ecotypes shape progression of lung adenocarcinoma from ground-glass opacity toward advanced stages.
Deng Y, Xia L, Zhang J, Deng S, Wang M, Wei S
Cell Rep Med. 2024; 5(4):101489.
PMID: 38554705
PMC: 11031428.
DOI: 10.1016/j.xcrm.2024.101489.
Exploring the metastasis-related biomarker and carcinogenic mechanism in liver cancer based on single cell technology.
Zheng Q, Lu C, Yu L, Zhan Y, Chen Z
Heliyon. 2024; 10(6):e27473.
PMID: 38509894
PMC: 10950590.
DOI: 10.1016/j.heliyon.2024.e27473.
Matrix confinement modulates 3D spheroid sorting and burst-like collective migration.
Cai G, Li X, Lin S, Chen S, Rodgers N, Koning K
Acta Biomater. 2024; 179:192-206.
PMID: 38490482
PMC: 11263001.
DOI: 10.1016/j.actbio.2024.03.007.
Tumor-to-Tumor Metastasis of Lung Cancer to Kidney Cancer: A Review of the Literature and Our Experience.
Baston C, Parosanu A, Mihai M, Moldoveanu O, Stanciu I, Nitipir C
Diagnostics (Basel). 2024; 14(5).
PMID: 38473025
PMC: 10930794.
DOI: 10.3390/diagnostics14050553.
Phenotypic Heterogeneity, Bidirectionality, Universal Cues, Plasticity, Mechanics, and the Tumor Microenvironment Drive Cancer Metastasis.
Mierke C
Biomolecules. 2024; 14(2).
PMID: 38397421
PMC: 10887446.
DOI: 10.3390/biom14020184.
How important is EMT for cancer metastasis?.
Celia-Terrassa T, Kang Y
PLoS Biol. 2024; 22(2):e3002487.
PMID: 38324529
PMC: 10849258.
DOI: 10.1371/journal.pbio.3002487.
Multiplex protein imaging in tumour biology.
de Souza N, Zhao S, Bodenmiller B
Nat Rev Cancer. 2024; 24(3):171-191.
PMID: 38316945
DOI: 10.1038/s41568-023-00657-4.
RNA Modifications in Cancer Stem Cell Biology.
Cerneckis J, Cui Q, Liu W, Shi Y
Cancer Treat Res. 2023; 190:25-47.
PMID: 38112998
DOI: 10.1007/978-3-031-45654-1_2.